BioSante Pharmaceuticals, Inc. (BPAX)

All Comments on BPAX

  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:23 AM
    My Website
    General Discussion on BPAX
    Is this a buy or a sell? Reply
  • commenter
    User 124040
    Nov 20 09:58 AM
    My Top Four Emerging Micro-Cap Biotech Stocks [view article]
    thank you. Reply
  • commenter
    mikehav
    Nov 20 06:05 AM
    My Website
    My Top Four Emerging Micro-Cap Biotech Stocks [view article]
    The Emerging Micro-Cap Index (MIKE) was established on 7/21/07 at a starting value of 100.0 in order to track micro-cap and small-cap stocks with innovative technologies, excellent growth potential, and/or discount valuations across all sectors of the economy with an overweight position in healthcare. The index is equally weighted & actively managed to reflect the Top 25 stock opportunities that I follow. The index will be maintained at 25 stocks for a combination of diversification and the ability to produce meaningful returns. MIKE closed at 96.8 on 11/19/07, outperforming both its peer group and the overall market. Reply
  • commenter
    bobh
    Nov 19 06:49 PM
    My Top Four Emerging Micro-Cap Biotech Stocks [view article]
    If the merger brings new cancer drugs to people that need them, it would make the buyout price worth it. The NewsVisual article on Celgene has announced that it will acquire Pharmion Corp www.newsvisual.com/new... asserts that common connections between the two companies makes the deal more valuable. Reply
  • commenter
    mikehav
    Nov 19 02:10 PM
    My Website
    My Top Four Emerging Micro-Cap Biotech Stocks [view article]
    Check out these links to my free reports on the four stocks from this article & decide for yourself:

    mikehav.com/exas.pdf
    mikehav.com/cytx.pdf
    mikehav.com/bpax.pdf
    mikehav.com/tgen.pdf



    Reply
  • commenter
    Research Guy
    Nov 19 01:30 PM
    My Top Four Emerging Micro-Cap Biotech Stocks [view article]
    I would recommend against purchasing the author's research from his web page. The $5 I paid for one of the research reports was not worth the money. I found the report to lack analysis and really only told me what I already knew about the company in question.

    I bought the report thinking I would get some scientific insights that I am unable to arrive at on my own. Boy was I wrong! Mr. Havrilla claims to have scientific expertise, yet his reports do not reflect his knowledge claims.

    I was highly disappointed because the report lacked any sort of independent thought or analysis. From what I read, it appeared as if the author just regurgitated the 10-Q and other reports. If you are going to sell research please provide a thesis and independent analysis!

    Another question: why does he have stock picks in the Industrial and Financial sectors if he bills his website as one that touts Biotech stocks?

    I am all for people getting a start and building their research career but this is a joke!     Reply
Loading...
Symbols:
Authors:
Quick Links: